Potential beneficial effects of garlic in oncohematology

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 6, 2011, Pages 461-472

  Miroddi, M ^a   Calapai, F ^a   Calapai, G ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b Natural Medicine Consulting Room Azienda Ospedaliera G Martino ^*  (Italy)

Author keywords

Allium sativum; Cancer; Garlic; Leukaemia; Lymphoma; Oncohematology

Indexed keywords

AJOENE; ALLYL SULFIDE; CATALASE; DIALLYL DISULFIDE; DIALLYL TRISULFIDE; DITHIIN; GARLIC EXTRACT; GARLIC OIL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; S ALLYLMERCAPTOCYSTEINE; SULFUR; SULFUR DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CANCER MODEL; CANCER PREVENTION; CANCER RESEARCH; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; DRUG SYNTHESIS; GARLIC; HEMATOLOGIC MALIGNANCY; HISTONE ACETYLATION; HUMAN; IMMUNE RESPONSE; LEUKEMIA CELL; NONHUMAN; PROSTATE CANCER;

ALLYL COMPOUNDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE PROTEINS; DISULFIDES; GARLIC; HEMATOLOGIC NEOPLASMS; HISTONE DEACETYLASES; HUMANS; SULFIDES;

EID: 79959471386     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955711795843293     Document Type: Article

References (91)

1. Stan, S.D.; Kar, S.; Stoner, G.D.; Singh, S.V. Bioactive food components and cancer risk reduction. J. Cell. Biochem., 2008, 104, 339-356.
2. R.S. Rivlin, Historical perspective on the use of garlic, J. Nutr., 2001, 131, 951S-954S.
3. Block, E. The chemistry of garlic and onions. Sci. Am., 1985, 252, 114-119.
4. Iciek, M.; Kwiecień, I.; Włodek, L. Biological properties of garlic and garlic-derived organosulfur compounds. Environ. Mol. Mutagen., 2009, 50, 247-265.
5. K. Rahman, Historical perspective on garlic and cardiovascular disease, J. Nutr., 2001, 131, 977S-979S.
6. Butt, M.S.; Sultan, M.T.; Iqbal, J. Garlic: nature's protection against physiological threats. Crit. Rev. Food Sci. Nutr., 2009, 49, 538-551.
7. Amagase, H. Clarifying the real bioactive constituents of garlic. J. Nutr., 2006, 136, 716S-725S.
8. Weisberger, A.S.; Pensky, J. Tumor inhibition by a sulfhydrylblocking gent related to an active principle of garlic (Allium sativum). Cancer Res., 1958, 18, 1301-1308.
9. You, W.C.; Blot, WJ, Chang, YS; Ershow, A; Yang, Z.T.; An, Q.; Y.S. Chang, A. Ershow, Z.T. Yang, An, Q.; Henderson, B.E.; Fraumeni, J.F. Jr.; Wang, T.G. Allium vegetables and reduced risk of stomach cancer. J. Natl. Cancer. Inst., 1989, 81, 162-164.
10. Hsing, A.W.; Chokkalingam, A. P.; Gao, Y. T.; Madigan, M. P.; Deng, J.; Gridley, G. Allium vegetables and risk of prostate cancer: a population-based study. J. Natl. Cancer Inst., 2002, 94, 1648-1651.
11. Pinto, J. T., Lapsia S., Shah A., Santiago H.; Kim, G. In:, Nutrition and Cancer Prevention: New Insights into the Role of Phytochemicals, Antiproliferative effects of garlic-derived and other allium related compounds. American Institute for Cancer Research ed., Kluwer Academic/Plenum Publishers: New York, 2000; pp. 83-106.
12. Mei, X; Wang, M.C.; Xu, H.X.; Pan, X.P.; Gao, C.Y.; Han, N.; Fu, M.Y. Garlic and gastric cancer -The effect of garlic on nitrite and nitratein gastric juice. Acta Nutr. Sin., 1982, 4, 53-58.
13. Fleischauer, A.T; Poole, C.; Arab, L. Garlic consumption and cancer prevention: meta-analysis of colorectal and stomach cancers. Am. J. Clin. Nutr., 2000, 72, 1047-1052.
14. Lau, B.H.; Yamasaki T.; Gridley D.S. Garlic compounds modulate macrophage and T-lymphocyte functions. Mol. Biother., 1991, 3,103-107.
15. Ngo, S.N.T.; Williams, D.B.; Cobiac, L.; Head, R. J. Does garlic reduce risk of colorectal cancer? A systematic review. J. Nutr., 2007, 137, 2264-2269.
16. Agarwal, K.C.; Brisson, M.; Lazo, J.S.; Singh, S.V. Therapeutic actions of garlic constituents, Med. Res. Rev., 1996, 16, 111-124
17. Miron, T.; Mironchik, M.; Mirelman, D.; Wilchek, M.; Rabinkov, A. Inhibition of tumor growth by a novel approach: in situ allicin generation using targeted alliinase delivery. Mol. Cancer Ther., 2003, 2, 1295-1301.
18. Freeman, F.; Kodera, Y. Garlic chemistry: Stability of S-(2-propenyl)2-propene-1-sulfinothioate (allicin) inblood, solvent,andsimulatedphysiological fluids. J. Agric. Food. Chem., 1995, 43, 2332-2338.
19. Brodnitz, M.H; Pascale, J.V.; van Derslice, L. Flavor components of garlic extract. J. Agric. Food Chem., 1971,19, 273-275.
20. Rabinkov, A.; Miron, T.; Mirelman, D.; Wilchek, M.; Glozman, S.; Yavin, E.; Weiner, L. S-allylmercaptoglutathione: The reaction product of allicin with glutathione possesses SH-modifying and antioxidant properties. Biochim. Biophys. Acta, 2000, 1499,144-153.
21. Münchberg, U.; Anwar, A.; Mecklenburg, S.; Jacob, C. Polysulfides as biologically active ingredients of garlic Org. Biomol. Chem., 2007, 5, 1505-1518.
22. Jones, M.G.; Hughes, J.; Tregova, A.; Milner, J.; Tomsett, A.B.; Collin, H.A.; Biosynthesis of the flavour precursors of onion and garlic. J. Exp. Bot., 2004; 55, 1903-1918.
23. Amagase, H.; Petesch, B.L.; Matsuura, H.; Kasuga, S.; Itakura, Y. Intake of garlic and its bioactive components. J. Nutr., 2001, 131, 955S-962S.
24. Seki, T.; Tsuji, K.; Hayato, Y.; Moritomo, T.; Ariga, T. Garlic and onion oils inhibit proliferation and induce differentiation of HL-60 cells. Cancer Lett., 2000, 160, 29-35.
25. Corzo-Martinez, M.; Corzo, N.; Villamiel, M. Biological properties of onions and garlic. Trends Food Sci. Technol., 2007, 18, 609-625.
26. Munday, J.S.; James, KA; Fray, LM; Kirkwood S.W.; Thompson, K.G. Daily supplementation with aged garlic extract, but not raw garlic, protects low density lipoprotein against in vitro oxidation. Atherosclerosis, 1999, 143, 399-404.
27. Ibert, B.; Winkler, G.; Knobloch, K. Products of allicin transformation: ajoenes and dithins, characterisation and their determination by HPLC. Planta Med., 1990, 56, 202.
28. Dirsch, V.M.; Gerbes, A.L.; Vollmar, A.M. Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB. Mol. Pharmacol., 1998, 53, 402-407.
29. Lind, D.S. Arginine and cancer. J. Nutr., 2004, 134, 2837S-2841S.
30. Arnault, I.; Auger, J. Seleno-compounds in garlic and onion. J Chromatogr. A., 2006, 1112, 23-30.
31. Neuhouser, M.L. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr. Cancer, 2004, 50, 1-7.
32. Karmakar, S.; Banik, N.L.; Patel, S.J.; Ray, S.K. Garlic compounds induced calpain and intrinsic caspase cascade for apoptosis in human malignant neuroblastoma SH-SY5Y cells, Apoptosis, 2007, 12, 671-684.
33. Antosiewicz, J.; Herman-Antosiewicz, A.; Marynowski, S.W.; Singh, S.V. C-Jun NH(2)-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells, Cancer Res., 2006, 66, 5379-5386.
34. Druesne, N.; Pagniez, A.; Mayeur, C.; Thomas, M.; Cherbuy, C.; Duee, P.H.; Martel, P.; Chaumontet, C. Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines, Carcinogenesis, 2004, 25, 1227-1236.
35. Lea, M.A.; Rasheed, M.; Randolph, V.M.; Khan, F.; Shareef, A.; des Bordes, C. Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by Sallylmercaptocysteine. Nutr. Cancer, 2002, 43, 90-102.
36. Lea, M.A.; Randolph, V.M.; Patel, M. Increased acetylation of histones induced by diallyl disulfide and structurally related molecules. Int. J. Oncol., 1999, 15, 15347-15352.
37. Hassan, H.T. Ajoene (natural garlic compound): a new antileukaemia agent for AML therapy. Leuk. Res., 2004, 28, 667-671.
38. Shukla, Y.; Kalra, N. Cancer chemoprevention with garlic and its constituents, Cancer Lett., 2007, 247, 167-181.
39. Herman-Antosiewicz, A.; Powolny, A; Singh, S. V. Molecular targets of cancer chemoprevention by garlic-derived organosulfides. Acta Pharmacol. Sin., 2007, 28, 1355-1364.
40. Chun, H.S.; Kim, H.J.; Choi, E.H. Modulation of cytochrome P4501-mediated bioactivation of benzo[a]pyrene by volatile allyl sulfides in human hepatoma cells. Biosci. Biotechnol. Biochem., 2001, 65, 2205-2212.
41. Wargovich, M.J.; Woods, C.; Eng, V.W.; Stephens, L.C.; Gray, K. Chemoprevention of N-nitrosomethylbenzylamine induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide, Cancer Res., 1988, 48, 6872-6875.
42. Sheen, L.Y.; Chen, H.W.; Kung, Y.L.; Liu, C.T.; Lii, C.K. Effects of garlic oil and its organosulfur compounds on the activities of hepatic drug-metabolizing and antioxidant enzymes in rats fed high-and low-fat diets. Nutr. Cancer, 1999, 35, 160-166.
43. Sparnins, V.L.; Barany, G.; Wattenberg, L.W. Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione-S-transferase activity in the mouse. Carcinogenesis, 1988, 9, 131-134.
44. Yuan, J.P.; Ling, H., Zhang, M.X.; Liu, Y.; Song, Y.; Su, Q. Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC 803 cells involves activation of p38 MAPkinase pathways. Ai. Zheng, 2004, 23, 169-172.
45. Knowles, L.M.; Milner, J.A. Diallyl disulfide inhibits p34(cdc2) kinase activity through changes in complex formation and phosphorylation, Carcinogenesis, 2000, 21, 1129-1134.
46. Hartwell, L.H.; Weinert, T.A. Checkpoints: Controls that ensure the order of cell cycle events. Science, 1989, 246, 629-634.
47. Powolny, A.A.; Singh, S.V. Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Lett. 2008, 269, 305-314.
48. Xiao, D.; Herman-Antosiewicz, A.; Antosiewicz, J.; Xiao, H.; Brisson, M.; Lazo, J.S.; Singh, S.V. Diallyl trisulfide-induced G(2)-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc 25 C. Oncogene, 2005, 24, 6256-6268.
49. Khanum, F.; Anilakumar K.; Viswanathan K.R. Anticarcinogenic properties of garlic: a review. Crit Rev. Food Sci. Nutr., 2004, 44, 479-488.
50. Thompson C.A.; Habermann, T.M.; Wang, A.H.; Vierkant, R.A.; Folsom, A.R.; Ross, J.A.; Cerhan, J.R. Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin's lymphoma: the Iowa Women's Health Study. Int. J. Cancer, 2010, 126, 992-1003.
51. Hosono, T.; Fukao, T.; Ogihara, J; Ito, Y.; Shiba, H.; Seki, T.; Ariga, T. Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of beta-tubulin. J. Biol. Chem., 2005, 280, 41487-41493.
52. Filomeni, G.; Aquilano, K.; Rotilio, G.; Circolo, M.R. Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide. Cancer Res., 2003, 63, 5940-5949.
53. Antosiewicz, J.; Ziolkowski, W., Kar, S.; Powolny, A.A.; Singh, S.V. Role of reactive oxygen intermediates in cellular responses to dietary cancer chemopreventive agents. Planta Med., 2008, 74, 1570-1579.
54. Saravan, G.; Prakash, J. Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats. J. Ethnopharmacol., 2004, 94, 155-158.
55. McConkey, D.J.; Zhivotovsky, B; Orrenius, S. Apoptosis--molecular mechanisms and biomedical implications. Mol. Aspects Med., 1996, 17, 1-110.
56. Kaufmann, S.H.; Hengartner, M.O. Programmed cell death: Alive and well in the new millennium. Trends Cell. Biol., 2001, 11, 526-534
57. Farrow, S.N.; Brown, R. New members of the Bcl-2 family and their protein partners. Curr. Opin. Genet. Dev., 1996, 6, 45-49.
58. Espino, P.S., Drobic, B.; Dunn, K.J.; Davie, R. Histone modifications as a platform for cancer therapy. J. Cell. Biochem., 2005. 94, 1088-1102.
59. Malayeri, R.; Filipits, M; Suchomel, R.W.; Zochbauer, S.; Lechner, K.; Pirker,R. Multidrug resistance in leukemias and its reversal. Leuk. Lymph., 1996, 23, 451-458.
60. Arora, A.; Seth, K.; Shukla, Y. Reversal of P-glycoproteinmediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver. Carcinogenesis, 2004, 25, 941-949.
61. Kwon, K.B.; Yoo, S.J.; Ryu, D.G.; Yang, J.Y.; Rho, H.W.; Kim J.S.; Park, J.W.; Kim, H.R.; Park, B.H. Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem. Pharmacol., 2002, 63, 41-47.
62. Yu FS, Wu CC, Chen CT, Huang SP, Yang JS, Hsu YM, Wu PP, Ip SW, Lin JP, Lin JG, Chung JG. Diallyl sulfide inhibits murine WEHI-3 leukemia cells in BALB/c mice in vitro and in vivo. Hum. Exp. Toxicol., 2009, 28, 785-790.
63. Milner, J.A. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bio-activation: garlic and carcinogenesis. Adv. Exp. Med. Biol., 2001, 492, 499.
64. Fan, Z.L.; Qi, Z.H.; Xie, Y. Effect of diallyl disulfide on the expression and secretion of VEGF in HL-60 cells. Zhonghua Xue Ye Xue Za Zhi, 2006, 27, 626-629.
65. Yi, L.; Ji, X.X.; Lin, M.; Tan, H.; Tang, Y.; Wen, L.; Ma, Y.H.; Su, Q. Diallyl disulfide induces apoptosis in human leukemia HL-60 cells through activation of JNK mediated by reactive oxygen. Pharmazie. 2010, 65, 693-698.
66. Zheng, S.; Yang, H.; Zhang, S.; Wang, X.; Yu, L.; Lu, J.; Li, J. Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention. J. Cell. Biochem. Suppl., 1997, 27, 106-112.
67. Qi, R.; Liao, F.; Inoue, K.; Yatomi, Y.; Sato, K.; Ozaki, Y. Inhibition by diallyl trisulfide, a garlic component, of intracellular Ca(2+) mobilization without affecting inositol-1,4, 5-trisphosphate (IP(3)) formation in activated platelets. Biochem. Pharmacol., 2000, 60, 1475-1483.
68. Mehri, F.; Auger, J.; Rendu, F.; Bauvois, B. Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines. Biologic., 2008, 2, 885-895.
69. Ha, M.W.; Ma, R.; Shun, L.P.; Gong, Y.H.; Yuan, Y. Effects of allitridi on cell cycle arrest of human gastric cancer cells. World J. Gastroenterol., 2005, 11, 5433-5437.
70. Xiao, D.; Singh, S.V. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis, 2006, 27, 533-540.
71. Xiao, D.; Choi, S.; Johnson, D.E.; Vogel, V.G.; Johnson, C.S.; Trump, D.L.; Lee, Y.J.; Singh, S.V. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase mediated phosphorylation of Bcl-2, Oncogene, 2004, 23, 5594-5606.
72. Gallwitz, H.; Bonse, S.; Martinez-Cruz, A.; Schlichting, I.; Schumacher, K.; Krauth-Siegel, R.L. Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic, kinetic, and spectroscopic studies. J. Med. Chem., 1999, 42, 364-372.
73. Tadi, P.P.; Teel, R.W.; Lau, B.H. Organosulfur compounds of garlic modulate mutagenesis, metabolism, and DNA binding of aflatoxin B1. Nutr. Cancer., 1991, 15, 87-95.
74. Li, M.; Min, J.M.; Cui, J.R.; Zhang, L.H.; Wang, K.; Valette, A. Zajoene induces apoptosis of HL-60 cells: involvement of bcl-2 cleavage. Nutr. Cancer, 2002, 42, 241.
75. Dirsch, V.M.; Antlsperger, D.S.; Hentze, H.; Vollmar, A.M. Ajoene, an experimental anti-leukemic drug: mechanism of cell death. Leukemia, 2002, 16, 74.
76. Ahmed, N.; Laverick, L.; Sammons, J.; Zhang, H; Maslin, D.; Hassan, H.T. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34 positive CD7 negative resistant cells. Anticancer Res., 2001, 21, 3519.
77. Dirsch, V.M.; Gerbes, A.L.; Vollmar, A.M. Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB. Mol. Pharmacol., 1998, 53, 402-407.
78. Hunter, R.; Kaschula C.H.; Parker, I.M.; Caira, M.R.; Richards, P.; Travis, S.; Taute, F.; Qwebani, T. Substituted ajoenes as novel anticancer agents. Bioorg. Med. Chem. Lett., 2008, 1, 5277-5279.
79. Xiao, D; Pinto, J.T; Soh, J.W.; Deguchi, A.; Gundersen, G.G.; Palazzo, A.F.; Yoon, J.T.; Shirin, H.; Weinstein, I.B. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Cancer Res., 2003, 63, 6825-6837.
80. Sigounas, G.; Hooker, J.L.; Li, W.; Anagnostou, A.; Steiner, M. SAllylmercaptocysteine, inhibits cell proliferation and reduces the viability of erythroleukemia, breast and prostate cancer cell lines. Nutr. Cancer, 1997, 28, 186.
81. Arditti, F.D.; Rabinkov, A.; Miron, T.; Reisner, Y.; Berrebi, A.; Wilchek, M.; Mirelman, D. Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate. Mol. Cancer Ther. 2005, 4, 325-331.
82. Berginc, K., Trontelj, J., Kristl, A. The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices. Drug Metab Pharmacokinet. 2010, 25, 307-313.
83. Molassiotis, A., Fernadez-Ortega, Pud, P.D., Ozden, G.; Scott, J.A.; Panteli, V.; Marguli, A.; Browall, M.; Magri, M.; Selvekerova, S.; Madsen, E.; Milovics, L.; Bruyns, I.; Gudmundsdottir, G.; Hummerston, S.; Ahmad, A.M.A.; Platin, N.; Kearney, N.; E. Patiraki. Use of complementary and alternative medicine in cancer patients: a European survey. Ann. Oncol., 2005, 16, 655-663.
84. Ernst, E.; Resch, K.L.; Mills, S. Complementary medicine: a definition. Br. J. Gen. Pract., 1995, 45, 506.
85. Frankenfeld, C.L.; Cerhan, J.R.; Cozen, W.; Davis, S.; Schenk, M.; Morton, L.M.; Hartge, P.; Ward M.H. Dietary flavonoid intake and non-Hodgkin lymphoma risk. Am. J. Clin. Nutr., 2008, 87, 1439-1445.
86. Han, X.; Zheng, T.; Foss, F.; Holford, T.R.; Ma, S.; Zhao, P.; Dai, M.; Kim, C.; Zhang, Y.; Bai, Y.; Zhang, Y. Vegetable and fruit intake and non-Hodgkin lymphoma survival in Connecticut women. Leuk. Lymphoma., 2010, 51, 1047-1054.
87. Hassan, H.T.; Zander, A.R. Haematopoietic cytokines in the biology and treatment of acute myeloid leukaemia. Oncol. Rep., 1997, 4, 1141.
88. Hodge, G.; Davis, S.; Rice, M.; Tapp, H.; Saxon, B.; Revesz, T. Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL. Biologics. 2008, 2, 143-149.
89. Fugh-Berman, A.; Ernst, E. Herb-drug interactions: review and assessment of report reliability. Br. J. Clin. Pharmacol., 2001, 52, 587-595.
90. Demeule, M.; Brossard, M.; Turcotte, S.; Regina, A.; Jodoin, J.; Béliveau, R. Diallyl disulfide, a chemopreventive agent in garlic, induces multidrug resistance-associated protein 2 expression. Biochem. Biophys. Res. Commun. 2004, 324, 937-945.
91. Piasek, A.; Bartoszek, A.; Namiełnik, J. Phytochemicals that counteract the cardiotoxic side effects of cancer chemotherapy. Postepy Hig. Med. Dosw. 2009, 63, 142-158.